This Northern Cheyenne Doula Was About To Start Getting Paid — Then Medicaid Cuts Hit
LAME DEER, Mont. — Misty Pipe had about an hour before her shift began at…
This Northern Cheyenne Doula Was About To Start Getting Paid — Then Medicaid Cuts Hit
LAME DEER, Mont. — Misty Pipe had about an hour before her shift began at the post office. She used that time to check in on a new mom who lives a few miles outside this town at the heart of the Northern Cheyenne Indian Reservation. A mom of seven, Pipe is a doula on…
Can I Opt Out of Having My Doctor Take Notes With AI?
LISTEN: AI scribes are changing medical care. Here’s what to know if the technology shows up at your next doctor’s appointment. Family physician Eric Boose has been using an artificial intelligence tool to get back to what he calls “old-fashioned medicine” — talking with patients face-to-face, without having to type into a computer at the…
Digital Health Startups Raised $4B in Q1: How Cash Is Flowing Amid Uncertainty
Digital health funding rebounded in the first quarter of 2026, reaching $4 billion across 110 deals, according to data from Rock Health. The surge was fueled mainly by megadeals, reflecting a market where investors are placing larger bets on fewer startups. The post Digital Health Startups Raised $4B in Q1: How Cash Is Flowing Amid…
CEO Building AI’s “Health Universe” Utterly Unperturbed By Rivals
“We spend a lot of time focused on building the experiences that we think are the future of healthcare, and we don’t spend a heck of a lot of time worrying about what other people are doing,” declares Dan Caron, founder and CEO of Health Universe. Here’s a Q&A with the leader of the Kleiner…
TPA Yuzu Health Aims to Revamp Health Benefits with $35M Boost
Yuzu’s $35 million round was led by General Catalyst and Chemistry, with participation from Anthropic’s Anthology Fund, Bain Future Back Ventures, Timeless Ventures, Lachy Groom and Neo. The post TPA Yuzu Health Aims to Revamp Health Benefits with $35M Boost appeared first on MedCity News.
Neurocrine’s $2.9B Soleno Buyout Brings What Could Become Its Next Blockbuster Drug
Soleno Therapeutics brings Neurocrine Biosciences Vykat XR, a drug commercialized for treating the rare genetic disease Prader-Willi syndrome. This blockbuster prospect complements Crenessity, a Neurocrine drug approved for treating a rare endocrine disorder called congenital adrenal hyperplasia. The post Neurocrine’s $2.9B Soleno Buyout Brings What Could Become Its Next Blockbuster Drug appeared first on MedCity…
Global Health Funding in the FY 2027 President’s Budget Request
This budget summary provides an analysis of global health funding amounts provided in the President’s FY 2027 budget request.
A Closer Look at California’s Plans to Implement Work Requirements While Facing Major Budget Shortfalls Amid Cuts in Federal Medicaid Funding
This issue brief examines California’s Medicaid work requirement implementation plans to provide initial insight into how California is preparing to implement work requirements amid projected state budget shortfalls and changes in the 2025 reconciliation law.
From Data Ownership to Learning Velocity in Direct-to-Consumer Healthcare
As commercialization increasingly reflects direct engagement dynamics, differentiation depends less on the volume of data controlled and more on the speed at which systems incorporate feedback. The post From Data Ownership to Learning Velocity in Direct-to-Consumer Healthcare appeared first on MedCity News.
Not All Hospitals Have Equal Resources — Knowledge Sharing Can Help Level the Playing Field
Resource-sharing across large networks of hospitals allows people to receive a higher quality of care across the country, regardless of where they live or how well-resourced their local health system may be. The post Not All Hospitals Have Equal Resources — Knowledge Sharing Can Help Level the Playing Field appeared first on MedCity News.
